These medications, originally developed to manage Type 2 diabetes, have proven to help with sustainable weight loss, appetite control, and improving metabolic health
Wharton S, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al
Your digestive tract contains millions of GLP-1 receptors, and flooding them with medication before adaptation occurs triggers a cascade of adverse responses including severe nausea, vomiting, and constipation that often force dose reductions anyway
Follicles that are more activated frequently have higher AMH levels, which indicates a larger ovarian reserve
Heres how Ozempic and Wegovy compare in these areas
The class of drugs which these lawsuits focus on are glucagon like peptide 1 receptor agonists (GLP-1RA)